Use of a low molecular weight heparin (enoxaparin) as an anticoagulant for cardiopulmonary bypass (CPB).

被引:0
|
作者
Lutz, P [1 ]
Moody, C [1 ]
Levitsky, S [1 ]
机构
[1] DEACONESS HOSP,BOSTON,MA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3064 / 3064
页数:1
相关论文
共 50 条
  • [11] USE OF ENOXAPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN IN ARTERIAL RECONSTRUCTIVE SURGERY
    SAMAMA, CM
    MOUREN, S
    BRIDEL, MP
    COMBE, S
    KOSKAS, F
    KIEFFER, E
    VIARS, P
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1990, 9 (02): : 102 - 105
  • [12] Con: Heparin is not the best anticoagulant for cardiopulmonary bypass
    Fitch, JCK
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1996, 10 (06) : 819 - 821
  • [13] Pro: Heparin is the best anticoagulant for cardiopulmonary bypass
    Rinder, CS
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1996, 10 (06) : 816 - 818
  • [14] Use of a low molecular weight heparin (enoxaparin) in heparin-induced thrombocytopenia (HIT) with thrombosis.
    Lutz, P
    Fische, K
    Pomposelli, F
    BLOOD, 1996, 88 (10) : 3065 - 3065
  • [15] EFFECT OF PREOPERATIVE ANTICOAGULANT TREATMENT ON ACTIVATED COAGULATION TIME AND HEPARIN LEVELS DURING NORMOTHERMIC CARDIOPULMONARY BYPASS (CPB)
    LONGROIS, D
    GONCALVES, O
    DEPOIX, JP
    ENGUERAND, D
    PHILIP, Y
    MONTRAVERS, P
    CHATEL, D
    HVASS, U
    DESMONTS, JM
    BRITISH JOURNAL OF ANAESTHESIA, 1995, 74 : 31 - 31
  • [16] USE OF ENOXAPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN, IN ELECTIVE HIP-SURGERY
    PLANES, A
    VOCHELLE, N
    BOUTHIER, J
    FAGOLA, M
    BELLAUD, M
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1991, 17 : 296 - 303
  • [17] ANTICOAGULANT EFFECT OF A LOW-MOLECULAR-WEIGHT HEPARIN
    HARENBERG, J
    ZIMMERMAN, R
    DEVRIES, JX
    WEBER, E
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1986, 128 (29-30): : 541 - 542
  • [18] Enoxaparin is a low-molecular-weight heparin with a complex chemical structure and various non-anticoagulant properties
    Zyryanov, S. K.
    Ushkalova, E. A.
    TERAPEVTICHESKII ARKHIV, 2016, 88 (12) : 109 - 115
  • [19] Hemorrhagic complications in patients treated with anticoagulant doses of a low molecular weight heparin (enoxaparin) in routine hospital practice
    Ellis, Martin H.
    Hadari, Ruth
    Tchuvrero, Noa
    Shapira, Shirley
    Kovlenko, Irena
    Kozmiakova, Mariana
    Zissin, Rivka
    Elis, Avishay
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2006, 12 (02) : 199 - 204
  • [20] Immediate type hypersensitivity to low molecular weight heparin (enoxaparin)
    Velasco Arregui, A.
    Bernedo Belar, N.
    Villarreal Balza De Vallejo, O.
    Audicana Berasategi, M.
    Arruti Oyarzabal, N.
    Longo Areso, M.
    ALLERGY, 2017, 72 : 632 - 632